Imran Talat

Average Profitability
<0.0001%
Insider Buys Quantity
5
Insider Buys Sum
$106,499.24
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Imran Talat

According to the SEC Form 4 filings, Imran Talat, being in a position of

  1. Chief Executive Officer at Rani Therapeutics Holdings, Inc.,
    оver the last 12 months, has bought 10296 shares for $19,974, and sold 0 shares,
    over all time since 2023-11-07, has bought 50296 shares for $106,499, and sold 0 shares.

The largest purchase of all time was on 2023-11-29 and amounted to 20000 shares of Rani Therapeutics Holdings, Inc. for $41,000.

Biography of Imran Talat

No biography is available at this moment.

2024-12-09PurchaseRani Therapeutics Holdings, Inc.
RANI
Chief Executive Officer
10,296
0.018%
$1.94$19,974-15.8%
2023-12-06PurchaseRani Therapeutics Holdings, Inc.
RANI
Chief Executive Officer
10,000
0.0173%
$2.27$22,700+29.18%
2023-12-04PurchaseRani Therapeutics Holdings, Inc.
RANI
Chief Executive Officer
5,000
0.0101%
$2.57$12,850+34.14%
2023-11-29PurchaseRani Therapeutics Holdings, Inc.
RANI
Chief Executive Officer
20,000
0.0409%
$2.05$41,000+70.26%
2023-11-07PurchaseRani Therapeutics Holdings, Inc.
RANI
Chief Executive Officer
5,000
0.0095%
$2.00$9,975+67.17%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.